$202.830
+4.401 (+2.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AXSM Prediction & Forecast by Similar Chart Analysis
Alphio's AXSM stock price prediction model matches the current Axsome Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $202.63 (-0.10%). The 1-week path is $199.83 (-1.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Axsome Therapeutics, Inc. Stock?
Axsome Therapeutics is currently a hold. The stock has a current price of $199.02 and an RSI of 19.79, indicating it is oversold. However, the forward P/E ratio is extremely high at 370.37, suggesting that the stock may be overvalued at this time. While the company reported a strong 46% year-over-year revenue increase in Q2, reaching $218.4 million, and has a gross margin of 93.06%, the significant net losses and high forward P/E ratio raise concerns about its valuation. The main risk is the high forward P/E ratio of 370.37, which could indicate that the stock is overvalued if growth does not meet expectations.
AXSM stock price ended at $202.83 on Tuesday, after rising +2.17%
Axsome Therapeutics, Inc. (AXSM) last closed at $202.83, gaining +2.17%. These facts feed the 1-day and 1-week AXSM price prediction above.
Analyst Consensus
Axsome Therapeutics, Inc. (AXSM): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Axsome Therapeutics, Inc. (AXSM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AXSM, ranked by similarity.
Seasonality analysis for AXSM
Historically the probability of a positive September return for AXSM is 100.00%. July offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AXSM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $109.47 | $151.76 | $167.90 | -25.18% |
| Oct 2026 | $183.47 | $198.72 | $241.76 | -2.03% |
| Nov 2026 | $155.82 | $198.72 | $211.41 | -2.03% |
| Dec 2026 | $131.38 | $153.74 | $200.39 | -24.20% |
In 2026, Axsome Therapeutics, Inc. (AXSM) is projected to range from $109.47 to $241.76.
Axsome Therapeutics, Inc. 2026 monthly forecast
In Sep 2026, Axsome Therapeutics, Inc. is projected to average $151.76, with a low of $109.47 and high of $167.90.
In Oct 2026, Axsome Therapeutics, Inc. is projected to average $198.72, with a low of $183.47 and high of $241.76.
In Nov 2026, Axsome Therapeutics, Inc. is projected to average $198.72, with a low of $155.82 and high of $211.41.
In Dec 2026, Axsome Therapeutics, Inc. is projected to average $153.74, with a low of $131.38 and high of $200.39.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.